Improved Understanding of Biomarkers in Tumor Microenvironment Key for Treatment Decisions in NSCLC
Brian S. Henick, MD, discusses the importance of expanding on the current knowledge of biomarkers and the tumor microenvironment to enhance treatment approaches for patients with non–small cell lung cancer.
Source: onclive.com